The American healthcare system, a colossal $5.3 trillion sector, finds itself at a precarious tipping point, burdened by the immense pressure of a rapidly aging population, pervasive operational inefficiencies, and significant macroeconomic uncertainty. This critical juncture, described by industry
The era of treating value-based care as a series of experimental pilot programs has definitively ended, giving way to a new standard where it functions as an indispensable operational capability for healthcare organizations. Success is no longer measured by mere participation in alternative payment
Global health insurance giant Cigna has sent ripples through the industry by announcing a significant workforce reduction affecting approximately 2,000 employees, which comes at the same time the company revealed a major settlement with the Federal Trade Commission over drug pricing. The decision
The landscape of serious illness care in the United States is fraught with challenges, leaving millions of vulnerable patients and their families navigating a fragmented and often reactive healthcare system. In this high-stakes environment, health technology company Vynca has made a definitive move
A contentious federal pilot program designed to overhaul how safety-net hospitals are compensated for prescription drugs has been abruptly withdrawn by the Department of Health and Human Services (HHS) following a decisive legal challenge. The proposed 340B Rebate Model Pilot, which was set to
A dramatic transformation is underway within the American healthcare landscape, as the long-dominant fee-for-service model gives way to a system that rewards quality of care over quantity of procedures. At the forefront of this movement is Aledade, a company that has rapidly become a central force
